Yue Yam Ma

46 year

Consumer Services

Health Technology

Profile

Yue Yam Ma worked as a Manager of Investment & Investor Relations at C&O Pharmaceutical Technology (Holdings) Ltd.
from 2010 to 2011.
Ms. Ma completed an undergraduate degree at the National University of Singapore in 1999 and a graduate degree at The University of New South Wales in 2003.

Former positions of Yue Yam Ma

Companies	Position	End
C&O Pharmaceutical Technology (Holdings) Ltd. C&O Pharmaceutical Technology (Holdings) Ltd. Pharmaceuticals: MajorHealth Technology C&O Pharmaceutical Technology (Holdings) Ltd. manufactures and distributes pharmaceutical products. It offers anti-infection and gastrointestinal drugs, drugs for ageing adults, and specialized drugs. The firm's products are used for various indications, such as skin soft tissues infections, analgesic and antipyretic, indigestion or gastro esophageal reflux disorder, respiratory tract infections, sinusitis, hypertension and migraine. The company was founded by Lai Chi Ma and Bin Gao in 2003 and is headquartered in Hong Kong.	Chief Investment Officer	2011-09-27

See the detail of Yue Yam Ma's experience

Training of Yue Yam Ma

National University of Singapore	Undergraduate Degree
The University of New South Wales	Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Yue Yam Ma's experience

Connections

100 +

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	1
C&O Pharmaceutical Technology (Holdings) Ltd. C&O Pharmaceutical Technology (Holdings) Ltd. Pharmaceuticals: MajorHealth Technology C&O Pharmaceutical Technology (Holdings) Ltd. manufactures and distributes pharmaceutical products. It offers anti-infection and gastrointestinal drugs, drugs for ageing adults, and specialized drugs. The firm's products are used for various indications, such as skin soft tissues infections, analgesic and antipyretic, indigestion or gastro esophageal reflux disorder, respiratory tract infections, sinusitis, hypertension and migraine. The company was founded by Lai Chi Ma and Bin Gao in 2003 and is headquartered in Hong Kong.	Health Technology